ArticleIn vivo (Athens, Greece)

Administration of Nivolumab in Metastatic Renal Cell Cancer Following Treatment With mTOR Inhibitors.

Jindrich Kopecky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.